Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use

Infect Immun. 1990 May;58(5):1384-90. doi: 10.1128/iai.58.5.1384-1390.1990.

Abstract

We investigated the effect of a pH 4-treated human immunoglobulin preparation for intravenous use (pH4-G) on the production of tumor necrosis factor alpha (TNF-alpha) in vivo. The level of TNF-alpha in the sera of rabbits receiving pH4-G before lipopolysaccharide (LPS) injection was lower than that in rabbits receiving only LPS. Similarly, the in vitro production of TNF-alpha was suppressed by pH4-G. Rabbit peritoneal exudate cells stimulated with LPS in the presence of pH4-G produced less TNF-alpha than did those stimulated only with LPS. pH4-G, however, had no effect on various TNF-alpha activities, such as cytotoxicity against tumorigenic murine fibroblasts (L929 cells), induction of interleukin-1 production, or fever induction. These results indicate that pH4-G suppresses TNF-alpha production without affecting TNF-alpha activities. A suppressive effect on the expression of TNF-alpha mRNA was also observed.

MeSH terms

  • Animals
  • Dinoprostone / metabolism
  • Fever / etiology
  • Gene Expression / drug effects
  • Immunoglobulins / administration & dosage
  • Immunoglobulins / pharmacology*
  • Indomethacin / pharmacology
  • Infusions, Intravenous
  • Interleukin-1 / biosynthesis
  • Lipopolysaccharides / pharmacology
  • Male
  • RNA, Messenger / genetics
  • Rabbits
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Immunoglobulins
  • Interleukin-1
  • Lipopolysaccharides
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Dinoprostone
  • Indomethacin